Xiphopharyngeal (Pharyngeal) Cancer

Overview

Xiphopharyngeal cancer, more commonly referred to as pharyngeal cancer, is a malignant tumor that originates in the tissues of the pharynx — the hollow tube that runs from the back of the nose to the esophagus and includes the nasopharynx, oropharynx, and hypopharynx. The term “xiphopharyngeal” is occasionally used in older literature to describe tumors arising near the “xiphoid” (lower sternum) region that extend into the upper aerodigestive tract, but in modern practice the disease is categorized by the specific sub‑site within the pharynx.

Pharyngeal cancer accounts for roughly 2–3% of all cancers worldwide and is the 7th most common cancer in men and the 13th in women (World Health Organization, 2022). In the United States, about 54,000 new cases of head and neck cancers are diagnosed each year, with the oropharynx contributing ~60% of those cases.^{[1] CDC, 2024}

It most often affects adults between **50–70 years of age**, but younger patients can develop disease, especially when associated with high‑risk human papillomavirus (HPV) infection.

Symptoms

Early pharyngeal cancer may cause only mild or no symptoms, which is why routine examinations are important for at‑risk individuals. When symptoms appear, they can be persistent and progressively worsen.

General symptoms (present in most sub‑sites)

• Sore throat that does not improve with typical remedies.
• Hoarseness or changes in voice, especially after a short illness.
• Difficulty swallowing (dysphagia) – feeling that food sticks in the throat.
• Ear pain (otalgia) without an ear infection.
• Unexplained weight loss of 5% or more of body weight.
• Persistent cough or a feeling of a lump in the throat.
• Bad breath (halitosis) that does not improve with oral hygiene.

Site‑specific symptoms

• Nasopharyngeal cancer: nasal obstruction, frequent nosebleeds, watery eyes, or a feeling of pressure behind the eyes.
• Oropharyngeal cancer: sore throat, difficulty opening the mouth (trismus), swollen lymph nodes at the angle of the jaw, or a visible mass on the tonsil or base of the tongue.
• Hypopharyngeal cancer: pain radiating to the shoulder or back, a feeling of food “sticking” in the lower throat, and coughing up blood (hemoptysis).

Causes and Risk Factors

Pharyngeal cancer is not caused by a single factor; rather, a combination of environmental, viral, and genetic influences increase risk.

Major risk factors

• Tobacco use – cigarettes, cigars, pipe, smokeless tobacco, and betel quid. Risk rises proportionally with pack‑years.^{[2] NIH, 2023}
• Heavy alcohol consumption – regular intake of >2 drinks/day for men, >1 drink/day for women, especially when combined with tobacco.
• Human papillomavirus (HPV) – particularly HPV‑16. HPV‑positive oropharyngeal cancers now represent >70% of cases in high‑income countries.^{[3] Mayo Clinic, 2024}
• Age – incidence rises sharply after age 50.
• Gender – men are 2–3 times more likely to develop the disease.
• Diet low in fruits and vegetables – diets deficient in antioxidants may predispose.
• Occupational exposures – wood dust, asbestos, nickel, and certain chemicals (e.g., formaldehyde).
• Recurrent gastro‑esophageal reflux disease (GERD) – chronic acid exposure can irritate the hypopharynx.
• Immunosuppression – especially in HIV or organ transplant recipients.

Genetic susceptibility

While most cases are linked to lifestyle or viral factors, rare inherited syndromes (e.g., Fanconi anemia, Li‑Fraumeni) increase head‑and‑neck cancer risk. Family history of head‑and‑neck or esophageal cancer may warrant closer surveillance.

Diagnosis

Prompt, accurate diagnosis is essential for optimal outcomes. The work‑up typically follows a stepwise approach.

1. Clinical evaluation

• Comprehensive head‑and‑neck physical exam, including inspection of the oral cavity, oropharynx, and neck lymph nodes.
• Fiber‑optic nasopharyngoscopy or laryngoscopy to visualize the tumor directly.

2. Imaging studies

• Contrast‑enhanced CT (computed tomography) – defines bone involvement and deep soft‑tissue spread.
• MRI (magnetic resonance imaging) – superior for soft‑tissue detail, especially in the nasopharynx.
• PET‑CT (positron emission tomography with CT) – evaluates metabolic activity, detects distant metastases, and guides radiation planning.

3. Tissue diagnosis

• Biopsy – either office‑based punch/excisional biopsy or endoscopic-guided core needle biopsy under imaging guidance.
• Histopathology determines the cancer type (usually squamous cell carcinoma) and grade.
• Testing for HPV DNA or p16 immunohistochemistry is mandatory for oropharyngeal lesions, as it influences prognosis and treatment.

4. Staging

The American Joint Committee on Cancer (AJCC) 8th edition staging system is used, incorporating tumor size (T), nodal involvement (N), and presence of distant metastasis (M). Accurate staging guides therapy.

Treatment Options

Treatment is individualized based on tumor stage, location, HPV status, patient health, and personal preferences. Multidisciplinary care (otolaryngology, radiation oncology, medical oncology, speech‑language pathology, nutrition) yields the best results.

1. Early‑stage disease (Stage I‑II)

• Radiation therapy alone – 60–70 Gy over 6–7 weeks; high local control rates (>80%).
• Transoral robotic surgery (TORS) or transoral laser microsurgery (TLM) – minimally invasive removal of the tumor, often followed by a reduced radiation dose.

2. Locally advanced disease (Stage III‑IV)

• Concurrent chemoradiation – radiation (70 Gy) combined with cisplatin (100 mg/m² every 3 weeks) or weekly cetuximab for HPV‑negative tumors.
• Surgery + adjuvant therapy – extensive resection (e.g., mandibular swing, total pharyngectomy) followed by postoperative radiation ± chemotherapy.
• Induction chemotherapy (docetaxel, cisplatin, 5‑FU) may be used in selected cases to shrink large tumors before chemoradiation.

3. Recurrent or metastatic disease

• Systemic therapy – platinum‑based doublet (cisplatin + 5‑FU or carboplatin + paclitaxel) plus immunotherapy (nivolumab or pembrolizumab) per NCCN 2024 guidelines.
• Targeted therapy – EGFR inhibitors (cetuximab) for EGFR‑expressing tumors.
• Palliative radiation – to control pain, bleeding, or airway obstruction.

4. Supportive and lifestyle measures

• Professional dental evaluation before radiation to reduce osteoradionecrosis risk.
• Swallowing therapy with a speech‑language pathologist.
• Nutritional counseling; consider a feeding tube (PEG) if oral intake is unsafe.
• Smoking cessation programs and alcohol moderation counseling.

Living with Xiphopharyngeal (Pharyngeal) Cancer

Life after diagnosis involves physical, emotional, and practical adjustments. Below are evidence‑based tips to maintain quality of life.

Nutrition & Swallowing

• Eat small, frequent meals; choose soft, high‑protein foods (yogurt, scrambled eggs, pureed soups).
• Stay upright for 30 minutes after eating to reduce aspiration risk.
• Use a prescribed thickened liquid if thin liquids cause coughing.
• Work with a dietitian to monitor weight and vitamin‑B12, iron, and calcium levels.

Oral health

• Brush gently with a soft toothbrush after meals; fluoride rinse helps prevent decay.
• Report any mouth sores, dry mouth, or difficulty opening the jaw to your care team promptly.

Speech and Voice

• Early involvement of a speech‑language pathologist can preserve or restore voice function.
• Voice amplifiers or electrolarynx devices may be useful after total laryngectomy.

Emotional wellbeing

• Consider counseling, support groups (e.g., American Cancer Society), or mindfulness programs.
• Screen for depression or anxiety—treatable with therapy and, when appropriate, medication.

Follow‑up care

• First‑year post‑treatment visits every 1–3 months, then every 4–6 months for years 2‑5, and yearly thereafter.
• Physical exam, imaging as indicated, and routine labs (CBC, thyroid function) are standard.
• Promptly report new throat pain, trouble swallowing, or unexplained weight loss.

Prevention

Many risk factors are modifiable, offering a realistic pathway to lower incidence.

• Quit tobacco – use nicotine‑replacement therapy, counseling, or prescription meds (varenicline, bupropion). Risk drops to that of a non‑smoker after ~10 years of abstinence.
• Limit alcohol – keep intake below 1 drink/day for women, 2 for men.
• HPV vaccination – the 9‑valent vaccine (Gardasil 9) protects against HPV‑16/18; recommended for males and females ages 9–45.
• Healthy diet – emphasize fruits, vegetables, whole grains, and lean proteins.
• Oral hygiene – regular dental check‑ups can catch precancerous lesions early.
• Occupational safety – use protective equipment when handling wood dust, chemicals, or asbestos.
• Manage reflux – weight control, elevate the head of the bed, and proton‑pump inhibitors when indicated.

Complications

If left untreated or when treatment causes side effects, several serious complications may arise.

• Airway obstruction – tumor growth can block the airway, causing stridor or respiratory distress.
• Bleeding – friable tumor tissue may bleed profusely, especially after radiation.
• Swallowing dysfunction – leading to malnutrition, aspiration pneumonia, and weight loss.
• Osteoradionecrosis – death of jawbone after high‑dose radiation, presenting with pain and exposed bone.
• Dental decay and dry mouth (xerostomia) – due to salivary gland damage.
• Secondary cancers – radiation increases risk of thyroid, esophageal, or other head‑and‑neck cancers.
• Psychosocial impact – depression, social isolation, and body‑image concerns.

When to Seek Emergency Care

For all other concerns—new or worsening symptoms, side‑effect questions, or emotional distress—contact your oncology or primary‑care provider promptly.

References

1. Centers for Disease Control and Prevention. Head and Neck Cancers. Updated 2024. https://www.cdc.gov/cancer/headneck/
2. National Institutes of Health. Tobacco and Cancer Fact Sheet. 2023. https://www.cancer.gov/about-cancer/causes-prevention/risk/tobacco
3. Mayo Clinic. HPV and Oropharyngeal Cancer. 2024. https://www.mayoclinic.org/diseases-conditions/oropharyngeal-cancer/in-depth/hpv-and-oropharyngeal-cancer/art-20486218
4. World Health Organization. International Agency for Research on Cancer (IARC) – Cancer Fact Sheets. 2022. https://gco.iarc.fr/today
5. Cleveland Clinic. Pharyngeal Cancer (Throat Cancer) Treatment Options. 2023. https://my.clevelandclinic.org/health/diseases/16973-pharyngeal-cancer